Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | February 23, 2021 | February 24, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date February 23, 2021 · Filed February 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,529 |
Ending reported balance
After 2021-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-02-23 · Exercise / conversion · Acquired 3,530 · Balance 41,187 Row 2 · 2021-02-23 · Sale · Disposed 658 · Balance 40,529 F1: This transaction was executed in multiple trades at prices ranging from $281.62 to $281.79 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.29 · Expires 2021-05-07 | Direct | 0 |
Reported balance
After 2021-02-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-23 · Exercise / conversion · Disposed 3,530 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $281.62 to $281.79 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2018 Filed May 15, 2018 19:00 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-017499 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,593 F1 · kind: Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 13:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 7,740 | $0.00 Strike: $40.27 | $0.00 |
DisclosureSEC source: 0001127602-18-006500 · form4.xml · derivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,740 shares Expires 2018-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 13:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,872 | $108.70 | $312,172.04 |
DisclosureSEC source: 0001127602-18-006500 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,589 Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 13:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 7,740 | $40.27 | $311,689.80 |
DisclosureSEC source: 0001127602-18-006500 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 10:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-018160 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,721 F1 · kind: Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 19:59 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 10,710 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001127602-16-069107 · form4.xml · derivative · entry 3 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,710 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 19:59 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 4,564 | $71.57 | $326,645.48 |
DisclosureSEC source: 0001127602-16-069107 · form4.xml · nonDerivative · entry 2 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,285 Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 19:59 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 10,710 | $30.44 | $326,012.40 |
DisclosureSEC source: 0001127602-16-069107 · form4.xml · nonDerivative · entry 1 CHUBB STEPHEN D · CIK 0001144771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.